Operator
Good day and welcome to this Tapestry Conference Call. Today s call is being recorded. [Operator Instructions].
At this time for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations at Tapestry Christina Colone.
Christina Colone
Vice President, Investor Relations
Good morning. Thank you for joining us. With me today to discuss our second quarter results as well as our strategies and outlook are doing Joanne Crevoiserat, Tapestry s Chief Executive Officer and Andrea Shaw Resnick, Tapestry s Interim Chief Financial Officer.
Before we begin, we must point out that this conference call will involve certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. This includes projection for our business in the current or future quarters or fiscal years. Forward-looking statements are not guarantees and our actual results may differ materially from those expressed or implied in
GoPro Announces Fourth Quarter and Full Year 2020 Results
Subscribers Grow 145% Year-over-Year to 761,000
Cash Flow from Operations of $108 Million in Q4 2020
Q4 2020 GAAP EPS of $0.28; Non-GAAP EPS of $0.39
News provided by
Share this article
Share this article
SAN MATEO, Calif., Feb. 4, 2021 /PRNewswire/ GoPro, Inc. (NASDAQ: GPRO) today announced financial results for its fourth quarter and full year ended December 31, 2020 and posted management commentary on its investor relations website at https://investor.gopro.com. GoPro s shift to a more subscription-centric consumer-direct model is resulting in a simpler, more profitable business with materially better cash generation, said Nicholas Woodman, GoPro s founder and CEO. The steps we ve taken to improve our business during the pandemic should serve us very well when the world begins to recover in earnest but as a business, fortunately we don t have to wait for that to happen.
Operator
Good day and welcome to the Vista Outdoor Inc. Third Quarter Fiscal Year 2021 Earnings Call. [Operator Instructions]
At this time, I would like to turn the call over to Kelly Reisdorf. Please go ahead.
Kelly Reisdorf
Vice President, Chief Communications and Investor Relations Officer
Good morning, and thank you for joining us for our third quarter fiscal year 2021 earnings call. With me this morning is Chris Metz, Vista Outdoor s Chief Executive Officer; and Sudhanshu Priyadarshi, Senior Vice President and Chief Financial Officer and Jason Vanderbrink, President of Ammunition.
Before we begin, I d like to remind everyone that during today s call, we will be making several forward-looking statements, and we make these statements under the safe harbor provisions of the Private Securities Litigation Reform Act. These forward-looking statements reflect our best estimates and assumptions based on our understanding of information known to us today. These forward-looking s
Press release content from Business Wire. The AP news staff was not involved in its creation.
Tennant Company Completes Sale of Coatings Business
February 2, 2021 GMT
MINNEAPOLIS (BUSINESS WIRE) Feb 2, 2021
Tennant Company (“Tennant”) (NYSE: TNC), a world leader in the design, manufacture and marketing of solutions that help create a cleaner, safer, healthier world, today announced the Company has completed a sale of its coatings business, Tennant Coatings, to The Sherwin-Williams Company (NYSE: SHW).
“The sale of Tennant’s coatings business is our latest move in the ongoing implementation of our enterprise strategy specifically, winning where we have competitive advantage,” said Tennant CEO Chris Killingstad. “By divesting a business that is not central to our core strengths in industrial and commercial floor cleaning, we can redirect resources toward more strategic and profitable activities.”
Share this article
Share this article
MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020.
Second Quarter FY2021 Snapshot
Second quarter organic revenue increased by 19% (21% reported) to $224.3 million and 15% (16% reported) in the first half of fiscal 2021 to $428.5 million.
GAAP EPS was $1.15 versus $3.02 one year ago primarily relating to a non-recurring gain of approximately $121 million in our ChemoCentryx investment in the second quarter of fiscal 2020. Delivered record adjusted earnings per share (EPS) of $1.62 versus $1.08 one year ago.
Adjusted Operating Margin increased to 38.7% in the second quarter of fiscal 2021 compared to 33.4% in the second quarter of fiscal 2020.